A novel microfluidic liposomal formulation for the delivery of the SN-38 camptothecin: characterization and in vitro assessment of its cytotoxic effect on two tumor cell lines
Ana Casadó,1,2 M Lluïsa Sagristá,1 Margarita Mora1 1Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Barcelona, Spain; 2Communication and CSR Department, Hospital Clinic of Barcelona, Barcelona, Spain Purpose: Irinote...
Guardado en:
Autores principales: | Casadó A, Sagristá ML, Mora M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aecd036f5cc74c8c875a89621239b88d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Novel SN38 derivative-based liposome as anticancer prodrug: an in vitro and in vivo study
por: Wu C, et al.
Publicado: (2018) -
Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy
por: Xing J, et al.
Publicado: (2019) -
SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study
por: Fang YP, et al.
Publicado: (2018) -
In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes
por: Chen M, et al.
Publicado: (2017) -
Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy
por: Bi Y, et al.
Publicado: (2018)